Cargando…

Antifungal Activity and Mechanism of Action of the Co(III) Coordination Complexes With Diamine Chelate Ligands Against Reference and Clinical Strains of Candida spp.

Although many antifungal agents are available in clinical treatment, increasing resistance of fungi, especially Candida species, to the available drugs requires the development of new safe and non-toxic compounds with novel modes of action as effective treatment against resistant microorganisms. Cob...

Descripción completa

Detalles Bibliográficos
Autores principales: Turecka, Katarzyna, Chylewska, Agnieszka, Kawiak, Anna, Waleron, Krzysztof F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058090/
https://www.ncbi.nlm.nih.gov/pubmed/30072969
http://dx.doi.org/10.3389/fmicb.2018.01594
_version_ 1783341635169419264
author Turecka, Katarzyna
Chylewska, Agnieszka
Kawiak, Anna
Waleron, Krzysztof F.
author_facet Turecka, Katarzyna
Chylewska, Agnieszka
Kawiak, Anna
Waleron, Krzysztof F.
author_sort Turecka, Katarzyna
collection PubMed
description Although many antifungal agents are available in clinical treatment, increasing resistance of fungi, especially Candida species, to the available drugs requires the development of new safe and non-toxic compounds with novel modes of action as effective treatment against resistant microorganisms. Cobalt complexes are very interesting and attractive as potential candidates with antimicrobial activity. Their therapeutic uses as antiviral, antibacterial antifungal, antiparasitic, antitumour, transferrin transporters, and anti-inflammatory agents are being intensively investigated. In this study we examined the antifungal activity of Co(III) complexes with diamine chelate ligands against a broad spectrum of Candida species. Minimum inhibitory concentration was determined by the microbroth dilution method and with serial passaging assay; the synergistic antimicrobial activity of the tested complexes combined with two antifungal drugs (ketoconazole and amphotericin B) was made by checkerboard assay. The effects of Co(III) complexes on yeast cell morphology were studied by optical and transmission electron microscopy. The mode of action of Co(III) complexes on the yeast cell wall (sorbitol assay) and cell membrane (ergosterol assay) were investigated. The cytotoxic effects of the tested compounds on red blood cells and the human keratinocyte (HaCaT) cell line were also evaluated. The analyzed compounds revealed significant antifungal activity for selected strains of Candida species; [CoCl(2)(dap)(2)]Cl (1) and [CoCl(2)(en)(2)]Cl (2) were more effective than ketoconazole. Its probable mechanism of action did not involve the cell wall or ergosterol binding. However, the checkerboard assay showed, that the antifungal activity of ketoconazole increased in combination with the tested complexes of Co(III). Our results suggest that both diamine complexes with Co(III) analogs caused damage to mitochondrial membrane or the membrane of the endoplasmic reticulum. The effect was observed by transmission electron microscope. Co(III) complexes with diamine chelate ligands are non-toxic at concentrations active against Candida species. This study provides new data on potential antifungal drugs, especially against Candida species.
format Online
Article
Text
id pubmed-6058090
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-60580902018-08-02 Antifungal Activity and Mechanism of Action of the Co(III) Coordination Complexes With Diamine Chelate Ligands Against Reference and Clinical Strains of Candida spp. Turecka, Katarzyna Chylewska, Agnieszka Kawiak, Anna Waleron, Krzysztof F. Front Microbiol Microbiology Although many antifungal agents are available in clinical treatment, increasing resistance of fungi, especially Candida species, to the available drugs requires the development of new safe and non-toxic compounds with novel modes of action as effective treatment against resistant microorganisms. Cobalt complexes are very interesting and attractive as potential candidates with antimicrobial activity. Their therapeutic uses as antiviral, antibacterial antifungal, antiparasitic, antitumour, transferrin transporters, and anti-inflammatory agents are being intensively investigated. In this study we examined the antifungal activity of Co(III) complexes with diamine chelate ligands against a broad spectrum of Candida species. Minimum inhibitory concentration was determined by the microbroth dilution method and with serial passaging assay; the synergistic antimicrobial activity of the tested complexes combined with two antifungal drugs (ketoconazole and amphotericin B) was made by checkerboard assay. The effects of Co(III) complexes on yeast cell morphology were studied by optical and transmission electron microscopy. The mode of action of Co(III) complexes on the yeast cell wall (sorbitol assay) and cell membrane (ergosterol assay) were investigated. The cytotoxic effects of the tested compounds on red blood cells and the human keratinocyte (HaCaT) cell line were also evaluated. The analyzed compounds revealed significant antifungal activity for selected strains of Candida species; [CoCl(2)(dap)(2)]Cl (1) and [CoCl(2)(en)(2)]Cl (2) were more effective than ketoconazole. Its probable mechanism of action did not involve the cell wall or ergosterol binding. However, the checkerboard assay showed, that the antifungal activity of ketoconazole increased in combination with the tested complexes of Co(III). Our results suggest that both diamine complexes with Co(III) analogs caused damage to mitochondrial membrane or the membrane of the endoplasmic reticulum. The effect was observed by transmission electron microscope. Co(III) complexes with diamine chelate ligands are non-toxic at concentrations active against Candida species. This study provides new data on potential antifungal drugs, especially against Candida species. Frontiers Media S.A. 2018-07-18 /pmc/articles/PMC6058090/ /pubmed/30072969 http://dx.doi.org/10.3389/fmicb.2018.01594 Text en Copyright © 2018 Turecka, Chylewska, Kawiak and Waleron. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Microbiology
Turecka, Katarzyna
Chylewska, Agnieszka
Kawiak, Anna
Waleron, Krzysztof F.
Antifungal Activity and Mechanism of Action of the Co(III) Coordination Complexes With Diamine Chelate Ligands Against Reference and Clinical Strains of Candida spp.
title Antifungal Activity and Mechanism of Action of the Co(III) Coordination Complexes With Diamine Chelate Ligands Against Reference and Clinical Strains of Candida spp.
title_full Antifungal Activity and Mechanism of Action of the Co(III) Coordination Complexes With Diamine Chelate Ligands Against Reference and Clinical Strains of Candida spp.
title_fullStr Antifungal Activity and Mechanism of Action of the Co(III) Coordination Complexes With Diamine Chelate Ligands Against Reference and Clinical Strains of Candida spp.
title_full_unstemmed Antifungal Activity and Mechanism of Action of the Co(III) Coordination Complexes With Diamine Chelate Ligands Against Reference and Clinical Strains of Candida spp.
title_short Antifungal Activity and Mechanism of Action of the Co(III) Coordination Complexes With Diamine Chelate Ligands Against Reference and Clinical Strains of Candida spp.
title_sort antifungal activity and mechanism of action of the co(iii) coordination complexes with diamine chelate ligands against reference and clinical strains of candida spp.
topic Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058090/
https://www.ncbi.nlm.nih.gov/pubmed/30072969
http://dx.doi.org/10.3389/fmicb.2018.01594
work_keys_str_mv AT tureckakatarzyna antifungalactivityandmechanismofactionofthecoiiicoordinationcomplexeswithdiaminechelateligandsagainstreferenceandclinicalstrainsofcandidaspp
AT chylewskaagnieszka antifungalactivityandmechanismofactionofthecoiiicoordinationcomplexeswithdiaminechelateligandsagainstreferenceandclinicalstrainsofcandidaspp
AT kawiakanna antifungalactivityandmechanismofactionofthecoiiicoordinationcomplexeswithdiaminechelateligandsagainstreferenceandclinicalstrainsofcandidaspp
AT waleronkrzysztoff antifungalactivityandmechanismofactionofthecoiiicoordinationcomplexeswithdiaminechelateligandsagainstreferenceandclinicalstrainsofcandidaspp